Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

17 trials with published results (14%)

Research Maturity

62 completed trials (50% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.4%

3 terminated out of 124 trials

Success Rate

95.4%

+8.8% vs benchmark

Late-Stage Pipeline

2%

3 trials in Phase 3/4

Results Transparency

27%

17 of 62 completed with results

Key Signals

17 with results95% success

Data Visualizations

Phase Distribution

68Total
Not Applicable (58)
Early P 1 (2)
P 1 (3)
P 2 (2)
P 3 (2)
P 4 (1)

Trial Status

Completed62
Unknown23
Recruiting18
Not Yet Recruiting6
Active Not Recruiting6
Withdrawn4

Trial Success Rate

95.4%

Benchmark: 86.5%

Based on 62 completed trials

Clinical Trials (124)

Showing 20 of 20 trials
NCT07714109Active Not RecruitingPrimary

Twelve-lead Wearable Holter,MRI,CT,X-ray,Echocardiography

NCT07648329Not Yet Recruiting

Association Between Circulating BDNF Levels and Atrial Cardiomyopathy in Patients Undergoing Ablation for Persistent Atrial Fibrillation

NCT06164808Not ApplicableRecruitingPrimary

Cardiac Arrhythmia Telemetry; Conventional vs HeartWatch

NCT07622485Not ApplicableNot Yet Recruiting

In-Hospital Wearable-Based Monitoring Versus Standard Care in Cardiovascular Disease (INSPIRE)

NCT05298553Not ApplicableCompletedPrimary

Diagnostic Accuracy of WEARable TECHnology Single-lead ECG in Detecting Cardiac Arrhythmias

NCT06172699Completed

Assert-IQ Implantable Cardiac Monitor (ICM) Post Market Study

NCT03405740Not ApplicableActive Not RecruitingPrimary

Virtual E-health System for Implantable Cardioverter Defibrillators

NCT07571980Not Yet RecruitingPrimary

The Effects of Low-Flow and Normal-Flow Sevoflurane Anesthesia on Frontal QRS-T Angle and TP-e Interval

NCT07018596Not ApplicableRecruiting

NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System

NCT06696170Not ApplicableRecruiting

CellFX® Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System for Treatment of Atrial Fibrillation

NCT03049254Recruiting

Mayo AVC Registry and Biobank

NCT04843683Not ApplicableRecruitingPrimary

StereoTactic Ablative RadioTherapy of Cardiac Arrhythmias

NCT06071910Not ApplicableRecruiting

Emergency Resuscitative Endovascular Balloon Occlusion of the Aorta in Out of Hospital Cardiac Arrest

NCT05772182CompletedPrimary

Non-invasive Tool to Assess Electrophysiological Mechanisms in Cardiac Arrhythmias

NCT06795204Phase 1Completed

Effects of HSK3486 on Cardiac Repolarization in Health Subjects (TQT)

NCT05458648Completed

Single Center Pilot Study Using the ECGenius System to Collect Electrogram Data to Test an Ablation Impact Algorithm

NCT07236398Enrolling By Invitation

Modified Left Atrial Maze Procedure for Concomitant AF Ablation

NCT07205367Not ApplicableActive Not RecruitingPrimary

Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II

NCT07185412Not Yet RecruitingPrimary

Spanish Registry of Redo Procedures Following Pulmonary Vein Ablation by Pulsed Field Ablation Technology: RESET-PFA

NCT04774523Not ApplicableCompleted

Evaluation of the BIOTRONIK AutoAdapt Algorithm for Continuous Automatic Adaptive Cardiac Resynchronization

Scroll to load more

Research Network

Activity Timeline